Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 1 1

Status

Completed 5Not yet recruiting 3Terminated 2Recruiting 2

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other solid neoplasm 3

Conditions

Carcinoma, Non-Small-Cell Lung 76Breast Neoplasms 53Colorectal Neoplasms 51Neoplasms 38Advanced Solid Tumors 34Multiple Myeloma 32Prostatic Neoplasms 31Ovarian Neoplasms 28Neoplasm Metastasis 28Recurrence 27Lung Neoplasms 27Carcinoma, Hepatocellular 27Pancreatic Neoplasms 26Advanced Solid Tumor 22Small Cell Lung Carcinoma 20Leukemia, Myeloid, Acute 20Endometrial Neoplasms 19Melanoma 18Triple Negative Breast Neoplasms 16Squamous Cell Carcinoma of Head and Neck 14Lymphoma, Follicular 14Stomach Neoplasms 13Lymphoma, B-Cell 13Glioma 13Glioblastoma 13Uterine Cervical Neoplasms 12Lymphoma 11Head and Neck Neoplasms 11Solid Tumor 10Myasthenia Gravis 9

Interventions

Platinum 1Injections 1Infusions, Intravenous 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × INDUSTRY × Metastatic Solid Tumors × Clear all
NCT07462442 2026-03-10

Study of QLS5308 in Patients With Advanced Solid Tumors

Qilu Pharmaceutical Co., Ltd.

Phase 1 Not yet recruiting
192 enrolled
Other solid neoplasm

Metastatic Solid Tumors

NCT07272590 2025-12-09

Study of QLC5513 in Combination With Epalolimab Tovolimab (QL1706) ± Platinum in Patients With Advanced or Metastatic Malignant Solid Tumors

Qilu Pharmaceutical Co., Ltd.

Phase 1/2 Not yet recruiting
290 enrolled
Other solid neoplasm

Metastatic Solid Tumors

NCT07249892 2025-11-25

A Study of BPR-6023021 in Advanced Solid Tumors With Bone Metastases

Chengdu Syncor Pharmaceutical Co., Ltd.

Phase 1/2 Not yet recruiting
195 enrolled
Other solid neoplasm

Metastatic Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡